Literature DB >> 29287728

[Towards a national strategy on the diagnosis of neurocognitive disorders. A shared approach among the French National College of General Practitioners and specialists of neurocognitive disorders].

Pierre Krolak-Salmon1, Laurent Letrilliart2, Mathieu Ceccaldi3, Sandrine Andrieu4, Olivier Guérin5, Bruno Dubois6, Bruno Brochet7, Pierre Vandel8, Claude Jeandel9, Armelle Leperre-Desplanques10, Michel Clanet11, Pierre-Louis Druais12.   

Abstract

Neurocognitive disorders leading to progressive cognitive, functional and behavioural impairment are often undiagnosed or diagnosed lately. But tailored care and therapeutics help in implementing secondary and tertiary prevention dynamics aiming at preserving quality of life and delaying, anticipating or preventing behavioural crisis and severe stages of dementia. Moreover, the diagnosis of numerous diseases induces specific care and therapeutics, as well access to research and clinical trials. For the first time, the representatives of the National College of General Practitioners, the French Federation of Memory Centres, the French Federation of Gerontology and Geriatrics, the French Federation of Neurology, the French Society of Psychogeriatrics and the national plan on neurodegenerative diseases propose a graduated and tailored diagnosis strategy involving primary care and specialists of neurocognitive disorders. This strategy has been built in the context of the national plan on neurodegenerative diseases, the European Joint Action "Act on dementia", and has been consensually agreed after a seminar animated by the National College of General Practitioners in March 2017.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29287728     DOI: 10.1016/j.lpm.2017.10.029

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  1 in total

1.  How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.

Authors:  Stéphane Epelbaum; Claire Paquet; Jacques Hugon; Julien Dumurgier; David Wallon; Didier Hannequin; Thérèse Jonveaux; Annick Besozzi; Stéphane Pouponneau; Caroline Hommet; Frederic Blanc; Laetitia Berly; Adrien Julian; Marc Paccalin; Florence Pasquier; Julie Bellet; Claire Boutoleau-Bretonniere; Thiphaine Charriau; Olivier Rouaud; Olivier Madec; Aurélie Mouton; Renaud David; Samir Bekadar; Roxane Fabre; Emmanuelle Liegey; Walter Deberdt; Philippe Robert; Bruno Dubois
Journal:  BMJ Open       Date:  2019-06-24       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.